Effect of minocycline postconditioning and ischemic postconditioning on myocardial ischemia-reperfusion injury in atherosclerosis rabbits

Abstract

This study examined the protective effect of ischemic postconditioning (IPoC) and minocycline postconditioning (MT) on myocardial ischemia-reperfusion (I/R) injury in atherosclerosis (AS) animals and the possible mechanism. Forty male healthy rabbits were injected with bovine serum albumin following feeding on a high fat diet for 6 weeks to establish AS model. AS rabbits were randomly divided into 3 groups: (1) I/R group, the rabbits were subjected to myocardial ischemia for 35 min and then reperfusion for 12 h; (2) IPoC group, the myocardial ischemia lasted for 35 min, and then reperfusion for 20 s and ischemia for 20 s [a total of 3 cycles (R20s/I20s×3)], and then reperfusion was sustained for 12 h; (3) MT group, minocycline was intravenously injected 10 min before reperfusion. The blood lipids, malondialdehyde (MDA), superoxide dismutase (SOD), soluble cell adhesion molecule (sICAM), myeloperoxidase (MPO), and cardiac troponin T (cTnT) were biochemically determined. The myocardial infarction size (IS) and apoptosis index (AI) were measured by pathological examination. The expression of bcl-2 and caspase-3 was detected in the myocardial tissue by using reverse transcription-polymerase chain reaction (RT-PCR). The results showed that the AS models were successfully established. The myocardial IS, the plasma levels of MDA, sICAM, MPO and cTnT, and the enzymatic activity of MPO were significantly decreased, and the plasma SOD activity was significantly increased in IPoC group and MT group as compared with I/R group (P<0.05 for all). The myocardial AI and the caspase-3 mRNA expression were lower and the bcl-2 mRNA expression was higher in IPoC and MT groups than those in I/R group (all P<0.05). It is concluded that the IPoC and MT can effectively reduce the I/R injury in the AS rabbits, and the mechanisms involved anti-oxidation, anti-inflammation, up-regulation of bcl-2 expression and down-regulation of caspase-3 expression. Minocycline can be used as an effective pharmacologic postconditioning drug to protect myocardia from I/R injury.

Keywords

minocycline / pharmacologic postconditioning / ischemic postconditioning / myocardial ischemia-reperfusion / atherosclerosis

References

[1] ZhaoZ.Q., CorveraJ.S., HalkosM.E., et al.. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol, 2003, 285(2): H579-H588

[2] PennaC., MancardiD., RaimondoS., et al.. The paradigm of postconditioning to protect the heart. J Cell Mol Med, 2008, 12(2): 435-458

[3] WakenoM., MinaminoT., SeguchiO., et al.. Long-term stimulation of adenosin A2b receptors begun after myocardial infarction prevents cariac remodeling in rats. Circulation, 2006, 114(18): 1923-1932

[4] RossA.M., GibbonsR.J., StoneG.W., et al.. A randomized, double-blinded placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol, 2005, 45(11): 1775-1780

[5] KlonerR.A., FormanM.B., GibbonsR.J., et al.. Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: the AMISTAD-2 trial. Eur Heart J, 2006, 27(20): 2400-2405

[6] KerendiF., KinH., HalkosM.E., et al.. Remote postconditioning: Brief renal ischemia and reperfusion applied before coronary artery reperfusion reduces myocardial infarct size via endogenous activation of adenosine receptors. Basic Res Cardiol, 2005, 100(5): 404-412

[7] LiuX., QuF.. Caspase inhibitors and neurologic diseases. Chin J Clin Neurosci (Chinese), 2005, 13(2): 218-222

[8] ZhangJ.C., XinJ.B., XiangF., et al.. A multi center randomized clinical study of minocycline hydrochloride on the treatment of respiratory and urinary track infections. Chin J Antibiot, 2008, 33(8): 483-486

[9] ZhuS., StavrovskayaI.G., DrozdaM., et al.. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature, 2002, 417(6884): 74-78

[10] ZhangW., NarayananM., FriedlanderR.M.. Additive neuroprotective effects of minocycline with creatine in a mouse model of ALS. Ann Neurol, 2003, 53(2): 267-270

[11] WuD.C., Jackson-LewI., IlaM., et al.. Blockade of microglial activation is neuroprotective in the 1-methyl-4 -phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci, 2002, 22(5): 1763-1771

[12] ShenX.Y., WangX.J.. Effects of minocycline on activity and expression of Caspase-3 induced by focal cerebral ischemia following reperfusion. Herald Med (Chinese), 2009, 28(2): 175-178

[13] YangJ.W., HuZ.P.. Study on the influence of minocycling on pathological changes of the ischemia-reperfusion brain tissue of gerbils. Pharm Clin Res (Chinese), 2008, 16(4): 265-268

[14] ScarabelliT.M., StephanouA., PasiniE., et al.. Minocycline inhibits caspase activation and reactivation, increases the ratio of XIAP to smac/DIABLO, and reduces the mitochondrial leakage of cytochrome C and smac/DIABLO. J Am Coll Cardiol, 2004, 43(5): 865-874

[15] YuX.D., WuX.H., DuX.W., et al.. Protective effects of minocycline on renal ischemia-reperfusion injury in rats. J Chongqing Med Univ (Chinese), 2007, 32(11): 1172-1174

[16] ZhaoX.M., SunS., LiuX.H.. Experimental model of myocardial ischemia/reperfusion in rat established by ligating coronary artery with capsule. J Chin Microcirc, 2007, 32(11): 206-208

[17] YellonD.M., HausenloyD.J.. Myocardial reperfusion injury. N Engl J Med, 2007, 357(11): 1121-1135

[18] HausenloyD.J.. Signalling pathways in ischaemic postconditioning. Thromb Haemost, 2009, 101(4): 626-634

[19] KohliV., MaddenJ.F., BentleyR.C., et al.. Calpain mediates ischemic injury of the myocardium through modulation of apoptosis and necrosis. Gastroenterology, 1999, 116(1): 168-178

[20] EeftingF., RensingB., WigmanJ., et al.. Role of apoptosis in reperfusion injury. Cardiovasc Res, 2004, 61(3): 414-426

[21] IliodromitisE., ZogaA., VrettouA., et al.. The effectiveness of postconditioning and preconditioning on infarct size in hypercholesterolemic and normal anesthetized rabbits. Atherosclerosis, 2006, 188(2): 356-362

[22] DonatoM., D’AnnunzioV., BergG., et al.. Ischemic postconditioning reduces infarct size by activation of A1 receptors and K+(ATP) channels in both normal and hypercholesterolemic rabbits. Cardiovasc Pharmacol, 2007, 49(5): 287-292

[23] MykytenkoJ., KerendiF., ReevesJ.G., et al.. Long-term inhibition of myocardial infarction by postconditioning during reperfusion. Basic Res Cardiol, 2007, 102(1): 90-100

[24] HélèneT., ChristopheP., PatrickS., et al.. Long-term benefit of postconditioning. Circulation, 2008, 17(8): 1037-1044

[25] VijayvergiyaR., AgarwalN., BahlA., et al.. Association of Chlamydia pneumoniae and Helicobacter pylori infection with angiographically demonstrated coronary artery disease. Int J Cardiol, 2006, 107(3): 428-429

[26] PasceriV., PattiG., CammarotaG., et al.. Virulent strains of Helicobacter pylori and vascular diseases: a meta-analysis. Am Heart J, 2006, 151(6): 1215-1222

[27] SeymourG.J., FordP.J., CullinanM.P., et al.. Relationship between periodontal infections and systemic disease. Clin Microbiol Infect, 2007, 13(Suppl4): 3-10

[28] VcevA., NakicD., MrdenA., et al.. Helicobacter pylori infection and coronary artery disease. Coll Antropol, 2007, 31(3): 757-760

[29] DabiriH., RezadehbashiM., BadamiN., et al.. Detection of Chlamydia pneumoniae in atherosclerotic plaques of patients in Tehran, Iran. Jpn J Infect Dis, 2009, 62(3): 195-197